Potassium

News

Wockhardt gets USFDA nod for marketing Augmentin

Published December 4, 2008, 8:51 pm, Business Standard India

Pharmaceutical and biotechnology major Wockhardt received USFDA approval for marketing and oral suspension of a combination of Amoxycillin and Clavulanate Potassium.

Full Story

Tags

No tags found at this time. Be the first to tag this news item, learn more.

Imagery


Related Potassium Stories

From Various News Sources

Wockhardt gets USFDA nod for marketing Augmentin - Business Standard
The company?s Chicago-based subsidiary Morton Grove Pharamaceuticals received approval for marketing the suspension containing 250 mg/ 5ml of Amoxycillin and 62.5mg/ 5ml of Clavulanate Potassium, which is used for treating several common infections ...

Wockhardt`s US arm gets USFDA nod for `Augmentin` - MyIris
Pharmaceutical and biotechnology major Wockhardt, announced, on Thursday, December 04 that it`s Chicago- based subsidiary Morton Grove Pharmaceuticals has received an approval from US Food and Drug Administration (USFDA) for marketing an oral ...

Related Social Bookmarks

None found at this time.


News Directory

Get started fast by using a pre-defined news directory category

Breaking News
and Top Stories
Business
Earnings, Economy, Personal Finance, and Stock Markets
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss
Politics
Congress, Supreme Court, and White House
Science
Animals, Astronomy, Biotechnology, Space, and Weather
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis
Technology
Communications, Hardware, Internet, Personal Technology, and Software
United States
and Crimes and Trials
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East


© Copyright 2005-2006 News Meme, All Rights Reserved | More News | Link Index | OSWD Design

Powered by Odin Assemble 2.5a